TherapeuticsMD (TXMD) Appoints Hugh O’Dowd as CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
November 11, 2021 6:45 AM EST- Mr. ODowd to succeed Robert G. Finizio, effective on or before December 31, 2021 -
- Mr. Finizio appointed Vice Chair of the Board -
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD) (TXMD or the Company), an innovative, leading womens healthcare company, today announced key leadership changes, including the appointment of Hugh ODowd, the Companys current President, as the Companys Chief Executive Officer and member of the board of directors. Mr. ODowd will succeed Robert G. Finizio, the Companys Co-founder and... More
